Our Policy
Find Us
Dungarvan Enterprise Centre,
Old Friary Building,
Lower Main Street, Dungarvan,
Co. Waterford, X35 FX45,
Ireland.
Toxicology is a critical component of pharmaceutical development, ensuring the safety and efficacy of products before they reach the market. At ERA, we take pride in our team of experienced toxicology experts who play a vital role in evaluating and managing the potential risks associated with pharmaceutical compounds. Here’s how our toxicology services can benefit your organization:
Expert Toxicological Assessments:
Comprehensive Evaluations:
Our toxicology experts conduct comprehensive assessments of pharmaceutical compounds to identify potential toxic effects.
ERA evaluates data from preclinical studies and provides insights into potential safety concerns.
Risk Mitigation Strategies:
We work closely with you to develop risk mitigation strategies, ensuring that potential toxicities are adequately managed during drug development.
Our experts help you make informed decisions on the progression of compounds.
Regulatory Compliance:
Regulatory Liaison:
ERA acts as a liaison between your organization and regulatory authorities, providing expertise in toxicology-related regulatory interactions.
We assist in preparing and submitting toxicology data in regulatory submissions.
Data Compilation and Reporting:
Our team compiles and prepares toxicology data and reports for regulatory submissions.
ERA ensures that your submissions meet regulatory requirements and expectations.
Safety Pharmacology:
Study Design and Evaluation:
ERA assists in designing and evaluating safety pharmacology studies to assess the potential effects of pharmaceutical compounds on vital organ systems.
We help you identify and address safety concerns early in the development process.
Risk Assessment and Management:
Hazard Identification:
We identify and assess potential hazards associated with your compounds, taking into account factors such as dose, exposure, and patient population.
ERA provides guidance on appropriate risk management strategies.
Post-Marketing Surveillance:
Our experts support post-marketing surveillance efforts to monitor for unexpected adverse effects and ensure ongoing safety.
ERA assists in addressing safety concerns and regulatory reporting.
By partnering with ERA for toxicology expertise, you gain access to a team of dedicated professionals committed to ensuring the safety of pharmaceutical compounds throughout the development and regulatory approval process. Our commitment to rigorous assessment, risk management, regulatory compliance, and safety pharmacology supports your efforts to bring safe and effective products to market.